Mass spectrometry imaging in gynecological cancers: the best is yet to come

Mass spectrometry imaging in gynecological cancers: the best is yet to come

Abstract Mass spectrometry imaging (MSI) enables obtaining multidimensional results simultaneously in a single run, including regiospecificity and m/z values corresponding with specific proteins, peptides, lipids, etc. The knowledge obtained in this way allows for a multifaceted analysis of the stud...

Full description

Bibliographic Details
Main Authors: Dagmara Pietkiewicz, Szymon Plewa, Mikołaj Zaborowski, Timothy J. Garrett, Eliza Matuszewska, Zenon J. Kokot, Jan Matysiak
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Cancer Cell International
Subjects:
Mass spectrometry imaging
Cancer research
Ovarian cancer
Endometrial cancer
Vulvar cancer
Online Access:https://doi.org/10.1186/s12935-022-02832-3

Internet

https://doi.org/10.1186/s12935-022-02832-3

Similar Items